AKT1 and breast carcinoma: In the present study, we have revealed that antagonism of miR-21reversed EMT consistent with CSC phenotype via AKT and ERK1/2 pathways by targeting PTEN, indicates a molecular pathway which might relieve the malignant biological behaviors of breast cancers.